Here's Why HealthEquity (HQY) is a Strong Growth Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks Investment Research • Dec 10, 2025

HealthEquity (HQY) Moves to Buy: Rationale Behind the Upgrade

HealthEquity (HQY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Zacks Investment Research • Dec 10, 2025

Is HealthEquity (HQY) a Solid Growth Stock? 3 Reasons to Think "Yes"

HealthEquity (HQY) possesses solid growth attributes, which could help it handily outperform the market.

Zacks Investment Research • Dec 10, 2025

HealthEquity Stock Gains as Q3 Earnings Beat Estimates, Revenues Up Y/Y

HQY stock gains post Q3 results as earnings and revenue top estimates, supported by rising HSAs and stronger margins.

Zacks Investment Research • Dec 4, 2025

HealthEquity, Inc. (HQY) Q3 2026 Earnings Call Transcript

HealthEquity, Inc. (HQY) Q3 2026 Earnings Call Transcript

Seeking Alpha • Dec 4, 2025

HealthEquity Reports Third Quarter Ended October 31, 2025 Financial Results

Highlights of the third quarter include: Revenue increased 7% to $322.2 million. Net income per diluted share rose to $0.59 from $0.06 one year ago, and non-GAAP net income per diluted share increased 29% to $1.01.

GlobeNewsWire • Dec 3, 2025

HealthEquity (HQY) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates

The headline numbers for HealthEquity (HQY) give insight into how the company performed in the quarter ended October 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Zacks Investment Research • Dec 4, 2025

HealthEquity (HQY) Tops Q3 Earnings and Revenue Estimates

HealthEquity (HQY) came out with quarterly earnings of $1.01 per share, beating the Zacks Consensus Estimate of $0.9 per share. This compares to earnings of $0.78 per share a year ago.

Zacks Investment Research • Dec 3, 2025

HealthEquity: Flywheel Keeps Spinning

HealthEquity, Inc. remains an asset-light growth opportunity, with a $120/share price target supported by strong Q2 FY26 results. HQY's recurring, asset-linked revenues, 70%+ gross margins, and expanding HSA penetration drive robust returns and positive operating leverage. Management's disciplined capital allocation, improving cost structure, and new legislative tailwinds expand HQY's total addressable market and growth runway.

Seeking Alpha • Dec 2, 2025

Exploring Analyst Estimates for HealthEquity (HQY) Q3 Earnings, Beyond Revenue and EPS

Evaluate the expected performance of HealthEquity (HQY) for the quarter ended October 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Zacks Investment Research • Nov 27, 2025